Skip to Main Content

Is the next Lipitor on the way? When is a pandemic over-over? And what’s a Texas two-step?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain the looming end of Covid-19’s status as a federal emergency and what that does and doesn’t mean for public health. We also dig into the most interesting stories from a busy week of pharmaceutical earnings and discuss a legal setback for Johnson & Johnson.

For more on what we cover, here’s more on the emergency declaration; here’s the news on J&J; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.


Be sure to sign up on Apple Podcasts, Spotify, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Create a display name to comment

This name will appear with your comment